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A critical question for public health is whether, in
low- and middle-income countries (LMIC), the
increasing burden of cardiovascular disease (CVD)
concentrates more on the advantaged or on the dis-
advantaged sections of society, and how this social
patterning of CVD changes over time. Subramanian
and colleagues argue that CVD concentrates on the
rich in India, with limited evidence for the occurrence
of a shift towards the poor.1
Operationally, the social patterning of CVD in LMICs
can be usefully framed along two different perspec-
tives: (i) what is the current social patterning of CVD
based on reliable population-based epidemiological
data, acknowledging that few data are available in
LMICs; and (ii) what is the potential relevance of
different scenarios of social patterning of CVD on
policy development, considering that definite data
are not yet available in many LMICs but some tools
can help anticipate future trends (i.e. findings in
high-income countries, theory of the health transi-
tion, social theory about adoption of lifestyles, etc.).
Subramanian and colleagues mainly adopt the first
perspective (i.e. current factual evidence in India), al-
though they also attempt to draw some conclusions
on policy. They reviewed mainly cross-sectional
studies covering a fairly large time lapse (1969 to
2008), but there is little attempt to examine changes
in the social patterning of CVD/CVD risk factors
during this period. A clearer view on the social tran-
sition of CVD and related risk factors could have per-
haps emerged if they had restricted their review to
those studies using longitudinal data or repeated
cross-sectional surveys on the same population; or
by attempting to compare studies from different
time periods.
It seems to us that substantial evidence supports the
view that the socioeconomic gradient in CVD and
CVD risk factors is reversing from the rich to the
poor in those LMICs which are at an intermediate
stage of the health transition, and that such a shift
is likely to occur in those LMICs at an early stage of
the health transition (in which the burden of CVD
still concentrates among the rich). This frame is im-
portant as it provides a rationale for tackling CVD
among the poor at an early stage of the non-commu-
nicable disease (NCD) epidemics. Here a crucial ques-
tion arises: who are the poor? Referring to a study of
Pednekar et al., Subramanian and colleagues report
that age-adjusted CVD mortality in Mumbai was
654, 618, 518 and 450 (per 100 000) among men
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with, respectively, primary, middle, secondary and ter-
tiary education. Subramanian and colleagues reject
the interpretation that there is a negative association
between educational level and CVD because the CVD
mortality rate among the illiterates was 471 (per
100 000), which was higher than that of highly edu-
cated persons, yet lower than that of people with pri-
mary or intermediate education. It seems to us that
this result on the contrary clearly shows a negative
socioeconomic gradient in CVD mortality among the
literates.
It is unquestionable that the most socioeconomically
deprived individuals, who cannot meet the minimum
dietary energy requirement or indulge in unhealthy
behaviours associated with globalization, are inher-
ently less affected by obesity, diabetes, dyslipidaemia
and hypertension. This is true in India as in most
LMICs. However, we believe that the main issue,
from a global public health perspective, is whether
socioeconomic development (which inexorably ex-
tends to larger segments of the population world-
wide) drives a shift in the social patterning of CVD
and its risk factors towards the poor, and whether
this unfavourable trend could be mitigated by some
interventions. For example, the prevalence of tobacco
use, the largest avoidable risk factor for NCDs, is al-
ready consistently greater among the poor in most
LMICs (including India).2,3
We recently examined changes in the social pattern-
ing of CVD risk factors in the Republic of Seychelles
(a middle-income island state in the Indian Ocean),
based on serial cross-sectional surveys carried out be-
tween 1989 and 2004.4 Among men, current smoking
and heavy drinking were more prevalent in the
lower vs the higher socioeconomic groups throughout
the study period, but obesity was less prevalent. The
socioeconomic gradient in diabetes reversed over the
study period, with high prevalence shifting from in-
dividuals with high socioeconomic status (SES) to in-
dividuals with low SES. Hypercholesterolaemia was
less prevalent in the low vs the high SES groups in
1989, but the prevalence was similar in the two
groups in 2004. Similar changes were also observed
in women, where in addition a reversal in the SES
gradient in smoking was noted. These changes in the
social patterning of CVD risk factors over time paral-
lelled considerable socioeconomic development (the
national gross domestic product per capita rose from
US$600 in 1976 to US$8000 in 2004) and marked
changes in dietary patterns and physical activity
levels in the population.5 Results in Seychelles are
consistent with data in China,6 Brazil,7 seven coun-
tries in Africa8 and 39 LMICs;9 these findings support
the view that CVD risk factors do shift towards the
poor in LMICs along with economic development, glo-
balization, urbanization and the nutritional transition.
We understand the concern of Subramanian and
colleagues that shifting attention from communicable
to non-communicable diseases in countries such as
India, where the majority of the population still
lives on less than US$2 a day, might divert some re-
sources from the very poor to the less poor. However,
it is likely that interventions to prevent the increasing
burden of CVD and other NCDs among the poor will
be more successful if implemented early enough in
the health transition and before the reversal of the
social patterning of CVD is fully engaged.
Furthermore, and most importantly, there is now a
unique window of opportunity to curb the emergence
of CVD and other NCDs in LMICs at the global level.
The importance of addressing NCDs in LMICs and the
need to focus on the poor are well recognized in
recent evidence-based global health policy documents
such as the political declaration of the High-level
Meeting on the Prevention and Control of Non
Communicable Diseases of the General Assembly of
the United Nations (http://www.un.org/ga/search/
view_doc.asp?symbol¼A/66/L.1) or the World Health
Organization global action plan for the prevention and
control of NCDs 2013–2020, to be submitted to the
World Health Assembly in May 2013.
We believe that addressing NCDs in LMICs by im-
plementing cost-effective structural interventions to
tackle avoidable NCDs at both the population and in-
dividual levels, including universal coverage for care-
fully selected priority management approaches among
high risk individuals, is timely, justified and neces-
sary.10–12 The close links between several communic-
able and non-communicable diseases (i.e. HIV,
tuberculosis and NCDs), the possibility of integrating
treatment for both groups of diseases at the primary
care level, the strong impact of chronic diseases on
catastrophic expenditure and impoverishment, and
the need to address NCDs as part of the broader de-
velopment agenda further support this view.13
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It appears that some Western academics are still
caught in a time warp, like Rip van Winkle. An argu-
ment was advanced by a World Bank team in 1999,
that any action to control non-communicable
diseases (NCDs) would only help the rich and hurt
the global poor by increasing health inequity.1 This
has subsequently been refuted by many.2,3 Even the
World Bank changed its stance in 2007, declaring
that in ‘all countries and by any metric, NCDs account
for a large enough share of the disease burden of
the poor to merit serious policy response’.4 The
United Nations political resolution on NCDs, in
September 2011, also acknowledged that NCDs are
imposing health and developmental burdens on the
poor in low- and low-middle income countries.5
Despite this, Subramanian et al. have chosen to
rehash the same argument with regard to cardiovas-
cular disease (CVD) in India.6 In brief, they reviewed
the available published literature from India on the
association between socio-economic status (SES) and
cardiovascular (CV) risk factors or acute events or
mortality outcome. They demonstrated a positive gra-
dient in socio-economic status (SES) in the preva-
lence of one of the CV risk factors, obesity or
overweight in Indians, and postulated that CVD is a
concern for only the rich in India. In effect their
stated position was similar to the Gwatkin thesis
and it is disheartening that we have not moved
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